Previous studies have shown that agents that enhance the Nrf2/HO-1 signaling pathway can protect against cisplatin-induced and oxygen-glucose deprivation (OGD)-induced ototoxicity in HEI-OC1 cells and animal models [9,23,24,36]. Here, HMOX1 is linked to ototoxicity.